Japan Graves' disease Market Key Players, Trends, Sales, Supply, Demand, Analysis & Forecast to 2025

Japan Graves' disease market is growing at a CAGR of around 4.7% during the forecast period. According to the WHO, around 10.1% of the country's population is suffering from diabetes, among which, the individuals suffering from type-1 diabetes are more prone to develop Grave's disease in the near future. According to IDF, around 2.2 per thousand children and adolescents aged 14 years and below are suffering from type-1 diabetes in Japan. Thus, the prevalence of disease is likely to propel the Japan Graves' disease market growth during the forecast period.

Get Sample Copy of Japan Graves' disease Market at: https://www.omrglobal.com/request-sample/japan-graves-disease-market

Key Players - Abbott Laboratories Inc., Allergan PLC, Eli Lilly and Co., GlaxoSmithKline PLC, Johnson & Johnson, Macleods Pharmaceuticals Ltd., Merck & Co. Inc., Mylan NV, Novartis International AG, Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd.

Further, the two regulatory agencies responsible for the Grave's disease treatment products and services in Japan, includes, Ministry of Health Labor and Welfare (MHLW) and Pharmaceuticals and Medical Devices Agency (PMDA) which are responsible for the laws and regulation for medical devices & drugs and quality of pharmaceuticals and medical devices respectively.

According to the National Centre for Biotechnology Information (NCBI), in 2017, a range of childhood hyperthyroidism cases are accredited under Grave's disease. Moreover, pediatric patients consist of less than 5% of the total number of patients that are suffering from Grave's disease, wherein the prevalence rate of the disease in children and adolescents is around 0.02%. In Japan, around 40% of children have a familial history of the Graves' disease, with frequency rate of 2% to 3%.

For More Information, get A full report of Japan Graves' disease Market is available at: https://www.omrglobal.com/industry-reports/japan-graves-disease-market

Additionally, Japan Thyroid Association is a Tokyo-based organization that consists of a range of scientists that develop guidelines for the diagnosis and management of thyroid nodules. The committee is further organized in the examination of the prevalence of subclinical hypothyroidism in Japan. The organization has provided "Guidelines for the Treatment of Grave's Disease with Anti-thyroid Drug, in 2006", stating several standard therapeutic protocols to general physicians for the treatment of Grave's disease. Thus, such standard set by the government in Japan has created scope for the Japan Graves' disease market growth in the near future.

Market Segmentation

Graves' Disease Market by Diagnosis

o Ultrasound
o Imaging Tests
o Radioactive Iodine Uptake
o Blood Sample

Graves' Disease Market by Treatment

o Anti- Thyroid Medication
o Radioactive Iodine Therapy
o Surgery

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/japan-graves-disease-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.